Total Payments
$2,253
2024 Payments
$242.32
Companies
25
Transactions
78
Medicare Patients
1,248
Medicare Billing
$144,675
Payment Breakdown by Category
Food & Beverage$2,253 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,253 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $665.86 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $150.00 | 1 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $145.21 | 8 | $0 (2019) |
| PFIZER INC. | $145.00 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $117.58 | 6 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $112.82 | 6 | $0 (2019) |
| Boston Scientific Corporation | $109.14 | 5 | $0 (2020) |
| Ipsen Biopharmaceuticals, Inc | $108.59 | 1 | $0 (2017) |
| Genentech USA, Inc. | $105.74 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $86.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.32 | 2 | Janssen Biotech, Inc. ($150.00) |
| 2022 | $123.61 | 3 | E.R. Squibb & Sons, L.L.C. ($86.24) |
| 2021 | $105.74 | 1 | Genentech USA, Inc. ($105.74) |
| 2020 | $173.87 | 8 | Boston Scientific Corporation ($67.81) |
| 2019 | $620.72 | 23 | AbbVie, Inc. ($178.50) |
| 2018 | $657.91 | 30 | AbbVie, Inc. ($307.22) |
| 2017 | $328.62 | 11 | Ipsen Biopharmaceuticals, Inc ($108.59) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $92.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 10/12/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $86.24 | General |
| Category: Neuroscience | ||||||
| 03/25/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Neuroscience | ||||||
| 01/29/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: VIROLOGY | ||||||
| 07/14/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $105.74 | General |
| Category: Immunology | ||||||
| 10/10/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.09 | General |
| 10/08/2020 | Boston Scientific Corporation | ORCAPOD (Device) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: ENDOCHOICE/INFECTION PREVENTION | ||||||
| 07/11/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: VIROLOGY | ||||||
| 06/11/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.85 | General |
| 06/09/2020 | Boston Scientific Corporation | HABIB ENDOHPB (Device) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: CATHETERS | ||||||
| 02/26/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: VIROLOGY | ||||||
| 02/13/2020 | Boston Scientific Corporation | ORISE (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: POLYPECTOMY | ||||||
| 01/20/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.20 | General |
| 11/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Immunology | ||||||
| 10/27/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/18/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Gastroenterology | ||||||
| 08/28/2019 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $60.51 | General |
| Category: Virology | ||||||
| 07/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Viberzi | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Gastroenterology | ||||||
| 07/10/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $17.38 | General |
| Category: Gastroenterology | ||||||
| 07/03/2019 | Boston Scientific Corporation | ORISE (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: POLYPECTOMY | ||||||
| 07/01/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 330 | 404 | $279,984 | $36,493 |
| 2022 | 7 | 306 | 367 | $216,697 | $35,369 |
| 2021 | 5 | 262 | 337 | $178,845 | $31,904 |
| 2020 | 10 | 350 | 437 | $247,122 | $40,909 |
Total Patients
1,248
Total Services
1,545
Medicare Billing
$144,675
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 177 | $59,118 | $15,519 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $33,594 | $6,823 | 20.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 30 | 30 | $52,860 | $5,969 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 44 | $9,856 | $3,080 | 31.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 31 | $36,580 | $2,742 | 7.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $59,698 | $2,143 | 3.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $28,278 | $217.45 | 0.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 175 | $58,450 | $14,963 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $37,666 | $8,321 | 22.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $45,559 | $2,875 | 6.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 41 | $9,184 | $2,723 | 29.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 13 | 13 | $22,906 | $2,399 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 23 | $27,140 | $2,396 | 8.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $15,792 | $1,691 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 190 | $63,460 | $16,146 | 25.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $26,977 | $6,406 | 23.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 28 | 28 | $43,988 | $3,404 | 7.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 28 | 31 | $36,580 | $3,391 | 9.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 35 | $7,840 | $2,557 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 129 | 199 | $66,442 | $15,286 | 23.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 63 | 63 | $32,054 | $6,304 | 19.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 32 | 33 | $38,940 | $3,816 | 9.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 16 | 16 | $28,192 | $3,065 | 10.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 32 | $10,272 | $2,635 | 25.7% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 25 | 25 | $39,275 | $2,507 | 6.4% |
About Dr. Robert Barbati, MD
Dr. Robert Barbati, MD is a Gastroenterology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134219967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Barbati, MD has received a total of $2,253 in payments from pharmaceutical and medical device companies, with $242.32 received in 2024. These payments were reported across 78 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,253).
As a Medicare-enrolled provider, Barbati has provided services to 1,248 Medicare beneficiaries, totaling 1,545 services with total Medicare billing of $144,675. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Melbourne, FL
- Active Since 10/13/2006
- Last Updated 04/01/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134219967
Products in Payments
- Mavyret (Drug) $215.41
- TREMFYA (Drug) $150.00
- Humira (Biological) $147.63
- NUEDEXTA (Drug) $145.21
- XELJANZ (Drug) $145.00
- ZEPOSIA (Drug) $110.27
- Somatuline Depot 120mg-.5ml (Drug) $108.59
- OCREVUS (Biological) $105.74
- CLENPIQ (Drug) $92.45
- RINVOQ (Biological) $92.32
- XIFAXAN (Drug) $86.56
- Fibroscan (Device) $75.70
- MAVYRET (Drug) $71.26
- Trulance (Drug) $65.61
- Creon (Drug) $41.84
- ORISE (Device) $41.54
- Vimpat (Drug) $41.26
- Alinia (Drug) $33.17
- LINZESS (Drug) $28.56
- HABIB ENDOHPB (Device) $24.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Melbourne
Andrew Schmidt, Md, MD
Gastroenterology — Payments: $9,361
Gastroenterology $9,361
Shireen Gadallah, M.d, M.D
Gastroenterology — Payments: $6,843
Gastroenterology $6,843
Charles Farrington, Md, MD
Gastroenterology — Payments: $6,331
Gastroenterology $6,331
Dr. John Turse, Md, MD
Gastroenterology — Payments: $4,870
Gastroenterology $4,870
Dr. Peter Koretsky, Md, MD
Gastroenterology — Payments: $4,838
Gastroenterology $4,838
Dr. Gita Koshy, M.d, M.D
Gastroenterology — Payments: $4,501
Gastroenterology $4,501